Pacific Edge’s American dream

Pacific Edge’s American dream
The US Affordable Care Act can be tricky to navigate. (Image: Getty)
Paul McBeth
Pacific Edge has long wanted to crack the United States market, which it has seen for a long time as validating the hundreds of millions spent in developing its Cxbladder non-invasive cancer detection tool. More than 20 years since listing, after it was spun out of University of Otago research, the company has raised $297.23 million selling shares and convertible preference shares and as people exercised options to fund accumulated losses of $216.8m and counting. That’s not going to change any time soon after the company crashed...

More Markets

Key says insider trading claim without merit
Markets

Key says insider trading claim without merit

US claimants target the company's directors over share prices and trading.

Positive Gentrack result gives sharemarket a boost
Markets Market close

Positive Gentrack result gives sharemarket a boost

The S&P/NZX 50 Index closed at 11,720.8, up 35.92 points or 0.31%.

Comvita opens books to bidder, cuts costs
Markets

Comvita opens books to bidder, cuts costs

The honey firm is finding a further $10m in costs to cut as it also cuts back guidance.

The Warehouse forced back to basics
Markets

Rebecca Stevenson: The Warehouse forced back to basics

While its rivals were fighting for customers, The Warehouse obsessed about itself.